Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing
Cornelius Kürten(Essen University Hospital), Robert L. Ferris(University of Pittsburgh), Angen Liu(University of Pittsburgh), Shou‐Jiang Gao(UPMC Hillman Cancer Center), Lazar Vujanović(UPMC Hillman Cancer Center), Riyue Bao(University of Pittsburgh), Stephan Lang(Essen University Hospital), Robert Lafyatis(University of Pittsburgh Medical Center), Carly Reeder(University of Pittsburgh), Tullia C. Bruno(University of Pittsburgh), Xinghua Lu(Guangzhou Huali College), Xueer Chen(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Sayali Onkar(University of Pittsburgh), Jian Feng(Okayama University), Aditi Kulkarni(University of North Carolina at Chapel Hill), Anna K. Roble(University of Pittsburgh), Anthony R. Cillo(University of Pittsburgh), Seungwon Kim(UPMC Hillman Cancer Center), Dario A.A. Vignali(University of Pittsburgh), P.M.L. Santos(Universidade do Extremo Sul Catarinense), Tracy Tabib(University of Pittsburgh)
Cited by 303
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
|Nature|1992|768
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688